Northeast Pharmaceutical Group Co., Ltd. (000597.SZ)

CNY 5.44

(0.18%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 15.27 Billion 13.81 Billion 13.17 Billion 12.16 Billion 12.53 Billion 11.71 Billion
Total Current Assets 9.78 Billion 7.93 Billion 6.79 Billion 5.55 Billion 5.87 Billion 5.59 Billion
Cash And Short Term Investments 5.65 Billion 3.84 Billion 2.55 Billion 1.48 Billion 1.52 Billion 1.28 Billion
Cash and Cash Equivalents 5.65 Billion 3.84 Billion 2.55 Billion 1.48 Billion 1.52 Billion 1.28 Billion
Short Term Investments - - - - - -1.63 Million
Net Receivables 2.61 Billion 2.84 Billion 2.95 Billion 2.77 Billion 3.01 Billion 2.97 Billion
Inventory 1.36 Billion 1.22 Billion 1.24 Billion 1.25 Billion 1.28 Billion 1.27 Billion
Other Current Assets 151.22 Million 24.28 Million 44.87 Million 41.15 Million 54.27 Million 65.3 Million
Total Non-Current Assets 5.49 Billion 5.87 Billion 6.38 Billion 6.61 Billion 6.66 Billion 6.12 Billion
Net PPE 4.51 Billion 4.85 Billion 5.22 Billion 5.48 Billion 5.42 Billion 4.78 Billion
Good Will And Intangible Assets 850.61 Million 854.71 Million 978.13 Million 969.71 Million 946.21 Million 880.1 Million
Good Will 26.11 Million 26.11 Million 26.11 Million 26.11 Million 26.11 Million 26.11 Million
Intangible Assets 824.49 Million 828.59 Million 952.01 Million 943.59 Million 920.09 Million 853.98 Million
Long-Term Investments 2.00 1.00 2.24 Million 2.38 Million 2.11 Million 3.23 Million
Tax Assets 128.06 Million 109.2 Million 102.09 Million 88.98 Million 90.46 Million 86.75 Million
Other Non Current Assets 745.07 Thousand 63.38 Million 71.33 Million 62.91 Million 200.5 Million 373.47 Million
Other Assets - - - - - 1.00
Total Liabilities 9.95 Billion 9.09 Billion 8.88 Billion 8.04 Billion 8.62 Billion 8.12 Billion
Total Current Liabilities 9.56 Billion 8.42 Billion 8.19 Billion 7.31 Billion 7.89 Billion 6.65 Billion
Account Payables 1.39 Billion 4.32 Billion 3.69 Billion 2.76 Billion 2.69 Billion 2.52 Billion
Tax Payables 55.57 Million 155.57 Million 65.19 Million 85.68 Million 78.32 Million 62.96 Million
Short Term Debt 6.52 Billion 1.97 Billion 3.17 Billion 3.3 Billion 3.78 Billion 3.04 Billion
Deferred Revenue 131.16 Million 192.71 Million 1.31 Billion 1.23 Billion 1.3 Billion 62.96 Million
Other Current Liabilities 1.51 Billion 1.93 Billion 10.95 Million 11.92 Million 112.75 Million 1.02 Billion
Total Non Current Liabilities 389.3 Million 673.94 Million 690.64 Million 727.28 Million 722.75 Million 1.47 Billion
Long-Term Debt 352.8 Million 255.93 Million 217.96 Million 200 Million 150 Million 874.32 Million
Deferred Revenue Non Current 157.11 Million 174.71 Million 194.04 Million 213.32 Million 223.45 Million 215.56 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -125.83 Million 238 Million 273.2 Million 308.4 Million 343.6 Million 378.8 Million
Other Liabilities 1.00 - - - 1.00 1.00
Total Equity 5.15 Billion 4.71 Billion 4.29 Billion 4.12 Billion 3.91 Billion 3.59 Billion
Stock Holders Equity 4.98 Billion 4.55 Billion 4.14 Billion 3.98 Billion 3.81 Billion 3.47 Billion
Common Stock 1.42 Billion 1.43 Billion 1.34 Billion 1.35 Billion 904.72 Million 569.58 Million
Retained Earnings 1.01 Billion 805.17 Million 496.05 Million 416.09 Million 403.83 Million 253.82 Million
Accumulated other comprehensive income 462.4 Million 296.91 Million 425.24 Million 446.86 Million 406.2 Million 441.94 Million
Common Stock Equity 4.98 Billion 4.55 Billion 4.14 Billion 3.98 Billion 3.81 Billion 3.47 Billion
Capital Lease Obligation 31.28 Million 17.93 Million 17.96 Million 56.32 Million - -
Total Investments 2.00 1.00 2.24 Million 2.38 Million 2.11 Million 1.6 Million
Total Debt 6.91 Billion 2.23 Billion 3.39 Billion 3.5 Billion 3.93 Billion 3.04 Billion
Net Debt 1.26 Billion -1.61 Billion 847.35 Million 2.02 Billion 2.4 Billion 1.76 Billion

Balance Sheet Charts